Citrullinated peptides of peptidyl arginine deiminase 4 as major B-cell epitopes in patients with rheumatoid arthritis

类风湿性关节炎患者中肽基精氨酸脱亚胺酶 4 的瓜氨酸化肽是主要的 B 细胞表位

阅读:2

Abstract

OBJECTIVE: To identify new autoantibodies in rheumatoid arthritis (RA) patients' sera. METHODS: We tested serum samples from 55 patients with RA and 25 controls on arrays containing 188 peptides from the alpha and beta chains of fibrinogen, vimentin, histon 4, enolase, proteoglycan, filaggrin, collagen, and human peptidyl arginine deiminase 4 (hPAD4). To confirm the validity of our peptide array detection, we tested serum samples from 50 patients with RA and 42 controls on purified peptides by luminescent enzyme-linked immunosorbent assay (ELISA). RESULTS: We found citrullinated peptides from hPAD4 that were recognized almost uniquely by sera from patients with RA on peptide arrays and ELISA. Peptide P22/60 from hPAD4 is a better RA diagnostic tool than the major classical citrullinated B-cell epitopes from histon 4, proteoglycan, alpha fibrinogen, and enolase. CONCLUSION: We identified citrullinated peptides from hPAD4 as RA-specific autoantigens.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。